Literature DB >> 15670717

3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome.

Lina S Correa-Cerro1, Forbes D Porter.   

Abstract

In the final step of cholesterol synthesis, 7-dehydrocholesterol reductase (DHCR7) reduces the double bond at C7-8 of 7-dehydrocholesterol to yield cholesterol. Mutations of DHCR7 cause Smith-Lemli-Opitz syndrome (SLOS). Over 100 different mutations of DHCR7 have been identified in SLOS patients. SLOS is a classical multiple malformation, mental retardation syndrome, and was the first human malformation syndrome shown to result from an inborn error of cholesterol synthesis. This paper reviews the biochemical, molecular, and mutational aspects of DHCR7.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15670717     DOI: 10.1016/j.ymgme.2004.09.017

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  33 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

2.  The conserved Rieske oxygenase DAF-36/Neverland is a novel cholesterol-metabolizing enzyme.

Authors:  Takuji Yoshiyama-Yanagawa; Sora Enya; Yuko Shimada-Niwa; Shunsuke Yaguchi; Yoshikazu Haramoto; Takeshi Matsuya; Kensuke Shiomi; Yasunori Sasakura; Shuji Takahashi; Makoto Asashima; Hiroshi Kataoka; Ryusuke Niwa
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

Review 3.  The ins and outs of cholesterol in the vertebrate retina.

Authors:  Steven J Fliesler; Lionel Bretillon
Journal:  J Lipid Res       Date:  2010-09-22       Impact factor: 5.922

4.  Partial rescue of retinal function and sterol steady-state in a rat model of Smith-Lemli-Opitz syndrome.

Authors:  Steven J Fliesler; Dana K Vaughan; Erin C Jenewein; Michael J Richards; Barbara A Nagel; Neal S Peachey
Journal:  Pediatr Res       Date:  2007-03       Impact factor: 3.756

5.  Light-induced exacerbation of retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.

Authors:  Dana K Vaughan; Neal S Peachey; Michael J Richards; Blake Buchan; Steven J Fliesler
Journal:  Exp Eye Res       Date:  2005-12-19       Impact factor: 3.467

Review 6.  Recent insights into the Smith-Lemli-Opitz syndrome.

Authors:  H Yu; S B Patel
Journal:  Clin Genet       Date:  2005-11       Impact factor: 4.438

7.  Cholesterol biosynthesis from birth to adulthood in a mouse model for 7-dehydrosterol reductase deficiency (Smith-Lemli-Opitz syndrome).

Authors:  Josep Marcos; Cedric H L Shackleton; Madhavee M Buddhikot; Forbes D Porter; Gordon L Watson
Journal:  Steroids       Date:  2007-07-13       Impact factor: 2.668

8.  Molecular screening of Smith-Lemli-Opitz syndrome in pregnant women from the Czech Republic.

Authors:  I Blahakova; E Makaturova; L Kotrbova; M Soukupova; J Lastuvkova; L Kozak
Journal:  J Inherit Metab Dis       Date:  2007-11-12       Impact factor: 4.982

9.  Clinical utility gene card for: Smith-Lemli-Opitz Syndrome [SLOS].

Authors:  Martina Witsch-Baumgartner; Hilary Sawyer; Dorothea Haas
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

10.  Alteration of retinal rod outer segment membrane fluidity in a rat model of Smith-Lemli-Opitz syndrome.

Authors:  Kathleen Boesze-Battaglia; Monika Damek-Poprawa; Drake C Mitchell; Laura Greeley; Richard S Brush; Robert E Anderson; Michael J Richards; Steven J Fliesler
Journal:  J Lipid Res       Date:  2008-03-14       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.